Weatherford Announces First Quarter 2024 Results and Raises Full Year Margin Guidance
First quarter revenue of $1,358 million increased 15% year-over-year, led by international growth of 21% First quarter operating income of […]
Weatherford Announces $130 Million Credit Facility Increase to $680 Million and Notice to Redeem All of Its 6.50% Senior Notes Due 2028
HOUSTON, April 23, 2024 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford,” and together with its subsidiaries, the “Company,” […]
USCB Financial Holdings, Inc. Declares Quarterly Cash Dividend on Common Stock
MIAMI, April 23, 2024 (GLOBE NEWSWIRE) — USCB Financial Holdings, Inc. (the “Company”) (NASDAQ: USCB), the holding company for U.S. […]
Shoals Technologies Group, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
PORTLAND, Tenn., April 23, 2024 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the […]
Amalgamated Financial Corp. Announces a 50% Quarterly Dividend Increase
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) — Amalgamated Financial Corp. (“Amalgamated” or the “Company”) (Nasdaq: AMAL) today announced that […]
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, […]
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the […]
Millicom announces the re-issuance of its AGM and EGM Convening Notice
Millicom announces the re-issuance of its AGM and EGM Convening Notice Luxembourg, April 23, 2024 – Millicom today announced the […]
The Vita Coco Company Announces the Formation of The Vita Coco Community Foundation
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), […]
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and […]
